We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BNY
101
Bank of New York Mellon
BNY
$106B
| $83.4M | 0.19% |
1,766,754
+43,881
| +3% | +$2.05M |
|
102
Salesforce
CRM
$150B
| $83.4M | 0.19% |
1,011,391
+20,269
| +2% | +$1.62M |
|
103
Dominion Energy
D
$62.5B
| $81.7M | 0.19% |
1,052,949
+31,606
| +3% | +$2.39M |
|
104
General Motors
GM
$81.6B
| $81.6M | 0.19% |
2,307,859
+56,334
| +3% | +$2.06M |
|
105
FedEx
FDX
$73.5B
| $80.9M | 0.19% |
414,499
+3,779
| +0.9% | +$722K |
|
106
Elevance Health
ELV
$83.3B
| $80.7M | 0.19% |
488,232
+7,130
| +1% | +$1.13M |
|
|
AET
107
DELISTED
Aetna Inc
AET
| $80.7M | 0.19% |
632,990
-18,458
| -3% | -$2.32M |
|
108
Prudential Financial
PRU
$43.1B
| $79.4M | 0.19% |
744,220
+20,530
| +3% | +$2.22M |
|
109
Stryker
SYK
$132B
| $78.9M | 0.18% |
599,689
+10,012
| +2% | +$1.26M |
|
110
PayPal
PYPL
$51.6B
| $78.9M | 0.18% |
1,833,392
+3,017
| +0.2% | +$126K |
|
|
SCHW
111
Charles Schwab
SCHW
$184B
| $78.7M | 0.18% |
1,929,365
+33,644
| +2% | +$1.39M |
|
112
CSX Corp
CSX
$95.3B
| $78.7M | 0.18% |
5,069,295
-188,769
| -4% | -$2.88M |
|
113
General Dynamics
GD
$106B
| $77.5M | 0.18% |
414,114
+11,953
| +3% | +$2.21M |
|
114
Halliburton
HAL
$26.3B
| $77M | 0.18% |
1,564,097
+50,918
| +3% | +$2.74M |
|
|
RTN
115
DELISTED
Raytheon Company
RTN
| $76.8M | 0.18% |
503,572
+44,962
| +10% | +$6.76M |
|
116
Ford
F
$58.8B
| $76.7M | 0.18% |
6,592,641
+169,967
| +3% | +$2.11M |
|
117
CME Group
CME
$93.6B
| $76M | 0.18% |
639,879
-9,614
| -1% | -$1.16M |
|
118
Illinois Tool Works
ITW
$85.6B
| $75.7M | 0.18% |
571,742
+8,975
| +2% | +$1.16M |
|
119
Capital One
COF
$129B
| $72M | 0.17% |
830,811
+14,641
| +2% | +$1.3M |
|
120
Kinder Morgan
KMI
$70.6B
| $71.6M | 0.17% |
3,292,188
+119,163
| +4% | +$2.6M |
|
|
ESRX
121
DELISTED
Express Scripts Holding Company
ESRX
| $71M | 0.17% |
1,076,960
+12,415
| +1% | +$854K |
|
122
Emerson Electric
EMR
$84.7B
| $70.4M | 0.16% |
1,176,888
+36,961
| +3% | +$2.21M |
|
123
Northrop Grumman
NOC
$78.4B
| $69.4M | 0.16% |
291,691
+22,450
| +8% | +$5.33M |
|
|
MRSH
124
Marsh
MRSH
$90.9B
| $68.7M | 0.16% |
929,452
+76,704
| +9% | +$5.48M |
|
|
YHOO
125
DELISTED
Yahoo Inc
YHOO
| $68.4M | 0.16% |
1,473,318
+35,640
| +2% | +$1.59M |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.